← Weight Loss & Metabolic

AOD-9604

A peptide fragment (176-191) of human growth hormone that specifically stimulates lipolysis.

Dr. Jonathan Snipes, MDMedically reviewed by Dr. Jonathan Snipes, MD. Last reviewed May 6, 2026.
AOD-9604 dispensed by a licensed U.S. 503A compounding pharmacy

Verify us before you order

Targeted Fat LossNo Growth EffectsWell-ToleratedMetabolic Support

What It Is

AOD-9604 is a modified amino acid fragment of hGH. Unlike full growth hormone, it specifically targets fat breakdown without affecting blood sugar or growth.

How It Works

It stimulates the pituitary gland to speed up fat metabolism and inhibits lipogenesis (fat production). It does this without the broad effects of full HGH.

Who It's For

Those looking for targeted fat loss support without the systemic effects of growth hormone peptides. Works well as part of a comprehensive weight management protocol.

Who Should Avoid It

Generally well-tolerated. Avoid during pregnancy.

Ready to add AOD-9604?

A licensed provider reviews every order.


Protocol & Pricing

Pharmacy Price

$80

1.2mg/mL, 5mL vial (6mg total)

You pay pharmacy price. No markup.

Starting Dose

25 units (0.3mg)

Form

Injectable vial, 5mL


Your pharmacy label will read

AOD 9604

1.2 MG/ML (5 ML)

The label shows strength per mL, not the total in the vial.

What that means

  • 1.2mg/mL means 1.2mg in every mL.
  • The vial holds 5mL, so 1.2mg/mL × 5mL = 6mg in the vial.
  • Each 25-unit injection (0.25mL) gives you 0.3mg, about 20 injections per vial.

Dosing Protocol

25 units subcutaneous injection daily, Monday to Friday. 25 units = 0.25mL × 1.2mg/mL = 0.3mg per injection. 8 to 12 weeks on, 2 to 4 weeks off.

Beyond Use Date

60 Days from compounding (USP <797>)

A licensed U.S. 503A compounding pharmacy assigns this date and prints it on your vial label. Always follow the label.

Ready to add AOD-9604?

A licensed provider reviews every order.


Why this dose, and what the evidence shows

From our medical director's protocol for AOD-9604. Where the evidence is thin, it says so.

Why this dose

The protocol uses 0.3 mg five days per week.

This schedule provides a simple weekday treatment cycle and matches the vial quantity used for the protocol.

The Monday-through-Friday schedule comes from current clinical practice rather than a clinical trial establishing five-day dosing.


What the evidence shows

AOD-9604 has undergone human clinical research, including studies evaluating safety and weight-related outcomes.

Human obesity studies produced mixed results. A smaller study reported greater weight loss with AOD-9604 than placebo, while a larger study involving roughly 500 participants did not show a meaningful advantage over placebo.

Preclinical studies in obese animals reported effects on fat metabolism and body weight.

No published human study has established subcutaneous AOD-9604 as an effective weight-loss treatment. The injectable protocol therefore represents an extrapolation from earlier AOD-9604 research rather than a clinically established weight-loss regimen.

Each order also carries the $39 prescriber review. Pharmacy prices are the pharmacy's own; we add nothing to them.

Ready to add AOD-9604?

A licensed provider reviews every order.


Stacking Guide

Stacks Well With

Semaglutide/B12BPC-157CJC-1295/Ipamorelin

Ready to add AOD-9604?

A licensed provider reviews every order.


Growth hormone fragment fat-loss protocol

Read the AOD-9604 protocol guide

A growth hormone fragment built to burn fat without raising IGF-1. The rodent data is real, but the pivotal 534-subject obesity trial did not beat placebo and development stopped in 2007. Honest about the gap.

Read guide

Related Peptides


Independently tested

AOD-9604 certificate of analysis

All 5 AOD-9604 samples tested for sterility and endotoxin passed both. Latest sample received by the lab Oct 1, 2026.

Every AOD-9604 batch dispensed by a licensed U.S. 503A compounding pharmacy is independently tested by Eagle Analytical Services (FDA-registered, A2LA ISO 17025 accredited). Sterility testing checks that nothing grows in the sample; the USP <85> endotoxin test checks for bacterial toxins that can cause fever. Below is the lab's own report for each of the 5 most recent lots.

Lot LG342011009, received Oct 1, 2026

Sterility
PassCelsis Sterility Test. Started Oct 1, 2026, completed Oct 9, 2026
Bacterial endotoxin
PassUSP <85>. Measured <2 EU/mL, limit 1750 EU/mL. Started Oct 2, 2026, completed Oct 5, 2026
Sample, as printed
AOD 9604 1.2 MG/ML (5 ML) Injection
Lot #
LG342011009
Storage
Refrigerated
Received by lab
Oct 1, 2026
Laboratory
Eagle Analytical Services Inc., Houston, TX
Submission #
ETX-261001-0477
Signed
Alison Eng, Quality Control Manager
Scan of Eagle Analytical report ETX-261001-0477 for lot LG342011009. Opens the original PDF.
Eagle Analytical report ETX-261001-0477. Open the original PDF (opens in a new tab)

Eagle Analytical Services is an independent FDA-registered laboratory, A2LA accredited to ISO 17025, based in Houston, Texas. They have no commercial relationship with Rx Peps Direct. Rx Peps Direct prescribes; the pharmacy compounds and dispenses; Eagle tests every batch. Three separate companies. Results apply only to the tested sample as received. Browse our full quality program on the quality page.

Ready to add AOD-9604?

A licensed provider reviews every order.


How to get AOD-9604 prescribed online

AOD-9604 is available by prescription after an online medical review and dispensed for human use by a licensed 503A pharmacy. That is what separates it from research-use-only vials sold without a prescription. There is no membership, just a medical review fee per order, and automatic refills are optional.

  1. 1

    Complete a $39 medical review. Answer a short intake about your health history and your goals for AOD-9604. The $39 fee is the only charge Rx Peps Direct collects, paid once, not a recurring subscription.

  2. 2

    A licensed provider reviews it. A US-licensed clinician reviews your intake and, if AOD-9604 is appropriate for you, writes a patient-specific prescription. The starting dose is typically 25 units (0.3mg).

  3. 3

    The pharmacy compounds and ships it. A licensed 503A compounding pharmacy in Texas compounds AOD-9604 and ships it pre-reconstituted by FedEx overnight in a reusable cooled case. Your fill is a 5mL injectable vial at 1.2mg/mL (6mg total), labeled "AOD 9604 1.2 MG/ML (5 ML)", and you pay the pharmacy $80 per vial at wholesale, with no clinic markup, plus a $15 flat FedEx overnight shipping fee charged by the pharmacy.

Rx Peps Direct prescribes AOD-9604 in the 28 states plus Washington, DC where its medical team is licensed. Start your $39 medical review or browse all peptides for weight loss. Comparing services first? See how Rx Peps Direct stacks up against seven other providers in our best telehealth for compounded peptides comparison.

Ready to add AOD-9604?

A licensed provider reviews every order.


Common questions about AOD-9604

What is AOD-9604 and what does it do?
AOD-9604 is a synthetic 16-amino acid fragment of human growth hormone (residues 177 to 191) developed in the 1990s to retain the lipolytic (fat-burning) properties of growth hormone without the growth-stimulating or insulin-resistance effects. The peptide promotes lipolysis (fat breakdown) and inhibits lipogenesis (new fat formation) without affecting blood glucose or IGF-1.
Does AOD-9604 actually help with fat loss?
Animal studies and small human trials support AOD-9604's lipolytic effect. A 12-week 2007 trial showed modest weight loss (~3 percent versus placebo) in obese adults. The peptide is more often used as an adjunct to GLP-1s (tirzepatide or semaglutide) or as a stand-alone for patients who do not tolerate GLP-1 GI side effects. Effects are gradual and require consistent dosing for 8 to 12 weeks.
How is AOD-9604 dosed?
The Rx Peps Direct dose is 25 units (0.3 mg) on a U-100 insulin syringe, injected subcutaneously once daily, Monday to Friday. A licensed U.S. 503A compounding pharmacy compounds AOD-9604 at 1.2 mg/mL against Rx Peps Direct prescriptions, so 25 units is 0.25 mL; your provider confirms the dose at review. Protocols described elsewhere deliver 250 to 500 mcg per day on an empty stomach (food blunts the lipolytic effect). Most protocols run 8 to 12 weeks at a time.
Where and how do I inject AOD-9604?
Subcutaneous injection into the abdomen for systemic effect or directly over the area you want to target for localized lipolysis. Use a 31-gauge, 5/16-inch (8 mm) needle on a U-100 insulin syringe. Inject in the morning on an empty stomach for best lipolytic effect, ideally 30 to 60 minutes before fasted cardio if cardio is part of your protocol.
How is AOD-9604 supplied?
Compounded by a licensed U.S. 503A compounding pharmacy under a patient-specific prescription. Ships pre-reconstituted and ready to inject. Every batch is tested by Eagle Analytical Services for sterility (ScanRDI or Celsis) and bacterial endotoxin (USP <85>); the Certificate of Analysis is published on this product page.

Ready to add AOD-9604?

A licensed provider reviews every order.